Sangamo Therapeutics(us:SGMO)

    2.38

    -3.64%

    Updated on 2024-12-23

    Open:2.34
    Close:2.38
    High:2.59
    Low:2.34
    Pre Close:2.47
    Volume:4.38M
    Amount:10.85M
    Turnover:2.10%
    Shares:208.65M
    MarketCap:497.62M

    About Sangamo Therapeutics Company

    Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which consist of inflammatory and autoimmune diseases. It also offers complementary technology platforms such as gene therapy, ex vivo cell therapy, in vivo genome editing, and in vivo genome regulation. The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Richmond, CA.

    Company Name: Sangamo Therapeutics
    Company Address: 501 Canal Boulevard
    Employees: 405
    Fiscar Year: 12-31
    IPO Date: 2000-04-06
    CIK: 1001233

    View all SEC Filings

    About

    Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which consist of inflammatory and autoimmune diseases. It also offers complementary technology platforms such as gene therapy, ex vivo cell therapy, in vivo genome editing, and in vivo genome regulation. The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Richmond, CA.
    Address:501 Canal Boulevard

    Market Movers